Sat, June 20, 2026
AUS Edition NZ Edition UK Edition
CA Edition USA Edition IND Edition
Kalkine Media ASX Share Market News & Research
Kalkine Media ASX Share Market News & Research
  1. Home
  2. Companies
  3. IRMD
Healthcare
Facebook Twitter Linkedin

Iradimed Co (NASDAQ:IRMD)

92.2 USD

+1.110 1.219%
Last Updated at: 2026-06-18T20:03:00Z

Iradimed Co

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

1025 Willa Springs Drive, Winter Springs, FL, United States, 32708

407 677 8022

https://www.iradimed.com

Employees: 148

Key Executives

Sr. No. Name Title Year Born
1. Mr. Roger E. Susi Founder, Chairman, CEO & Pres 1953
2. Mr. Randy Waddell VP of Worldwide Sales & Marketing NA
3. Mr. John F. Glenn Chief Financial Officer 1962
4. Mr. Chris Williamson Exec. VP of Continuous Improvement & Information Technology NA
5. Mr. Matt Garner Controller NA
6. Mr. Roger E. Susi Founder, Chairman, CEO & President 1953
7. Mr. John F. Glenn CFO & Corporate Secretary 1962
8. Mr. Randy Waddell Vice President of Worldwide Sales & Marketing NA
9. Mr. Steve Kachelmeyer Vice President of Regulatory Affairs & Quality Assurance NA
10. Mr. Lynn Neuhardt Vice President of Research & Development NA

Peers

Sector: Healthcare

Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE(x) Forward PE(x) Price Sales TTM(x) Price to Book Value(x) Enterprise Value to Revenue(x) Enterprise Value to EBITDA(x)
ABT

Abbott Laboratories

 -0.090 0.102% 88.64 25.970 17.241 3.570 3.200 3.805 16.753
SYK

Stryker Corporation

 +6.660 2.212% 301.19 44.070 24.938 5.509 6.118 6.050 25.731
MDT

Medtronic PLC

 +1.200 1.536% 78.59 26.600 15.873 3.354 2.083 3.897 14.117
BSX

Boston Scientific Corp

 +0.340 0.756% 45.06 31.490 17.241 4.407 3.650 4.878 19.194

Income Statement

(Currency in USD)
Breakdown 31-12-2022 31-12-2021 31-12-2020 31-12-2019 31-12-2018
Income Before Tax 16.181M 9.836M -0.617M 9.043M 6.197M
Minority Interest - - - - -
Net Income 12.827M 9.325M 1.369M 9.631M 6.303M
Selling General Administrative 10.697M 9.771M 12.269M 10.451M 8.711M
Gross Profit 41.282M 32.05M 23.574M 29.701M 23.227M
Reconciled Depreciation 0.671M 1.407M 1.339M 1.242M 1.105M
Ebit 14.957M 9.818M -0.756M 8.647M 6.004M
Ebitda 15.628M 11.225M 0.583M 9.89M 7.109M
Depreciation And Amortization 0.671M 1.407M 1.339M 1.242M 1.105M
Operating Income 15.628M 9.818M -0.756M 8.647M 6.004M
Other Operating Expenses 37.676M 31.997M 32.473M 29.87M 24.435M
Interest Expense 0.582M 0.019M 0.139M 0.396M 0M
Tax Provision 3.353M 0.511M -1.986M -0.588M -0.106M
Interest Income 0.582M 0.035M 0.132M 0.389M 0.238M
Net Interest Income 0.582M 0.035M 0.132M 0.389M 0.238M
Income Tax Expense 3.353M 0.511M -1.986M -0.588M -0.106M
Total Revenue 53.303M 41.815M 31.717M 38.517M 30.439M
Total Operating Expenses 25.655M 22.232M 24.331M 21.054M 17.224M
Cost Of Revenue 12.021M 9.765M 8.143M 8.816M 7.212M
Total Other Income Expense Net 0.553M 0.019M 0.139M 0.396M 0.194M
Net Income From Continuing Ops 12.827M 9.325M 1.369M 9.631M 6.303M
Net Income Applicable To Common Shares 12.828M 9.325M 1.369M 9.631M 6.303M

Balance Sheet

(Currency in USD)
Breakdown 31-12-2023 31-12-2022 31-12-2021 31-12-2020 31-12-2019
Total Assets 92.156M 85.513M 82.881M 71.067M 66.729M
Intangible Assets 2.519M 2.069M 1.119M 0.961M 0.86M
Other Current Assets 1.193M 0.631M 1.001M 0.772M 0.408M
Total Liab 20.736M 11.841M 10.708M 9.682M 11.204M
Total Stockholder Equity 71.42M 73.672M 72.174M 61.385M 55.524M
Other Current Liab 11.472M 3.088M 3.21M 2.055M 2.953M
Common Stock 0.001M 0.001M 0.001M 0.001M 0.001M
Capital Stock 0.001M 0.001M 0.001M 0.001M 0.001M
Retained Earnings 43.258M 47.264M 46.995M 37.669M 36.3M
Good Will - - - - -
Other Assets 0M 1.35M 0.966M 6.37M 1.895M
Cash 49.762M 57.961M 62M 50.069M 43.482M
Cash And Equivalents - - - - -
Total Current Liabilities 16.327M 8.554M 6.823M 4.917M 5.859M
Current Deferred Revenue 2.57M 3.373M 2.553M 1.949M 1.671M
Net Debt -47.719M -55.756M -59.517M -47.354M -40.526M
Short Term Debt 0.428M 0.293M 0.277M 0.256M 0.241M
Short Long Term Debt - - - - -
Short Long Term Debt Total 2.043M 2.205M 2.482M 2.715M 2.956M
Other Stockholder Equity 28.161M 26.406M 25.161M 23.677M 19.192M
Property Plant Equipment - 2.4M 4.551M 2.12M 2.054M
Total Current Assets 76.001M 78.189M 76.245M 63.736M 58.964M
Long Term Investments - - - - -
Short Term Investments - 0M 0.502M 1.909M 2.768M
Net Receivables 12.224M 13.275M 5.137M 4.575M 7.293M
Long Term Debt - - - - -
Inventory 12.821M 5.369M 4.3M 3.934M 3.642M
Accounts Payable 1.857M 1.799M 0.783M 0.657M 0.994M
Accumulated Other Comprehensive Income - - 0.017M 0.037M 0.03M
Non Currrent Assets Other 4.823M 2.153M 0.201M 0.262M 0.232M
Non Current Assets Total 16.155M 7.323M 6.636M 7.331M 7.765M
Capital Lease Obligations 2.043M 2.205M 2.482M 2.715M 2.956M
Long Term Debt Total - - - - -

Cash Flow

(Currency in USD)
Breakdown 31-12-2022 31-12-2021 31-12-2020 31-12-2019 31-12-2018
Investments 0.5M 1.39M 0.884M 3.687M 1.78M
Total Cashflows From Investing Activities -1.375M 0.648M 0.247M 3.201M 1.516M
Total Cash From Financing Activities -12.706M 0.024M 0.522M 2.02M 0.93M
Net Income 12.828M 9.325M 1.369M 9.631M 6.303M
Change In Cash -4.039M 11.931M 6.587M 15.454M 9.822M
Begin Period Cash Flow 62M 50.069M 43.482M 28.028M 18.206M
End Period Cash Flow 57.961M 62M 50.069M 43.482M 28.028M
Total Cash From Operating Activities 10.043M 11.258M 5.817M 10.233M 7.376M
Depreciation 0.671M 1.407M 1.339M 1.242M 1.105M
Other Cashflows From Investing Activities -1.052M -0.259M -0.194M -0.118M -0.036M
Dividends Paid 12.559M 12.559M 12.559M 12.559M -
Change To Inventory -1.309M -0.393M -0.283M 0.124M -0.122M
Sale Purchase Of Stock 0.147M - - 0M 0M
Other Cashflows From Financing Activities -0.147M 0.024M 0.522M 2.02M 0.93M
Capital Expenditures 1.875M 0.742M 0.637M 0.486M 0.265M
Change In Working Capital -5.056M -1.576M -1.172M -1.967M -1.808M
Other Non Cash Items 0.149M 0.119M -0.07M 0.069M 0.156M
Free Cash Flow 8.168M 10.516M 5.181M 9.747M 7.111M

Funds

Sr. No. Name Purchased On Shares
1. BBH Partner Fund Small Cap Equity 2 years ago 250000
2. Vanguard Total Stock Mkt Idx Inv 2 years ago 236303
3. Ranger Micro Cap 2 years ago 223491
4. iShares Russell 2000 ETF 2 years ago 163738
5. Vanguard Institutional Extnd Mkt Idx Tr 2 years ago 116700
6. Acuitas US Microcap Strategy 2 years ago 85374
7. Fidelity Small Cap Index 2 years ago 75205
8. Isthmus Small Cap Core Equity 2 years ago 67958
9. Russell Inv US Small Cap Equity E 2 years ago 64992
10. iShares Russell 2000 Growth ETF 2 years ago 60398
11. DFA US Small Cap I 2 years ago 57164
12. DFA US Micro Cap I 2 years ago 56210
13. State St Russell Sm/Mid Cp® Indx NL Cl C 2 years ago 49549
14. Fidelity Extended Market Index 2 years ago 43147
15. Vanguard VIF Small Co Gr 2 years ago 39386
16. BlackRock Advantage Small Cap Gr Instl 2 years ago 37974
17. Bridge City Capital Small Cap Growth 2 years ago 36255
18. Ballast Small/Mid Cap ETF 2 years ago 30380
19. Russell Inv Small Cap Fund B 2 years ago 28417
20. Ballast SMidCap 2 years ago 27832

Institutions

Sr. No. Name Purchased On Shares
1. Nine Ten Capital Management LLC 2 years ago 809366
2. BlackRock Inc 2 years ago 651948
3. Soleus Capital Management, L.P. 2 years ago 643206
4. Renaissance Technologies Corp 2 years ago 580212
5. Vanguard Group Inc 2 years ago 426477
6. Copeland Capital Management, LLC 2 years ago 418149
7. Rk Capital Management, LLC 2 years ago 299200
8. Bares Capital Management Inc 2 years ago 279000
9. Ranger Investment Management LP 2 years ago 232019
10. Dimensional Fund Advisors, Inc. 2 years ago 216845
11. Geode Capital Management, LLC 2 years ago 158205
12. Acadian Asset Management LLC 2 years ago 156655
13. State Street Corporation 2 years ago 149737
14. Goldman Sachs Group Inc 2 years ago 108166
15. Resource Consulting Group Inc 2 years ago 103000
16. Hillsdale Investment Management Inc. 2 years ago 97400
17. Millennium Management LLC 2 years ago 97099
18. Northern Trust Corp 2 years ago 85604
19. Rice Hall James & Associates, LLC 2 years ago 76711
20. Morgan Stanley - Brokerage Accounts 2 years ago 72611
Disclaimer

Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Sponsored Articles

Related Articles

Code Price Chg %Chg
View All
Code Price Chg %Chg
View All
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Open in the App